Kenvue Inc.

Kenvue Inc. is a consumer health company built around everyday self-care, skin health, and essential health products sold under brands such as Tylenol, Listerine, Neutrogena, BAND-AID, Aveeno, Johnson’s, Nicorette, and Zyrtec. The company combines consumer marketing, scientific claims, and healthcare-professional trust to sell over-the-counter medicines, oral care, skin care, and personal care products in more than 165 countries.

19,6 %

58,1 %

9,7 %

−2,1 %

0.96

0.68

— Kenvue Inc.
%
Self Care41% Includes OTC medicines and consumer health products for pain, allergy, cough/cold, and smoking cessation.
Skin Health and Beauty28% Includes facial care, body care, and dermatologist-recommended skin brands such as Neutrogena and Aveeno.
Essential Health31% Includes oral care, baby care, and wound care products used in daily routines and basic household care.

Kenvue sells primarily through retail and consumer health channels to households that buy trusted, repeat-use products...

  • Mass retail and pharmacy channelsprimary

    Buy Tylenol, Listerine, Neutrogena, and other staples for broad consumer resale and shelf traffic.

  • Household consumersprimary

    Purchase everyday care products for pain relief, oral care, skin care, baby care, and first aid.

  • E-commerce and digital shopperssecondary

    Buy through online marketplaces and direct digital channels where search, reviews, and convenience matter.

  • Healthcare-influenced consumerssecondary

    Choose products such as Nicorette, Zyrtec, and Tylenol based on efficacy and professional recommendation.

Kenvue operates globally across North America, APAC, EMEA, and LATAM, with products marketed in more than 165 countries...

  • •Sales span North America, APAC, EMEA, and LATAM
  • •Products are marketed in more than 165 countries
  • •Global manufacturing footprint supports supply flexibility
  • •China demand and shopping patterns have affected skin health
  • •U.S. retailer inventory management has impacted volumes

Kenvue is focused on transforming into a more efficient, digitally enabled consumer health company while improving...

01
Operational transformation and cost reductionshort-term

Lower overhead and improve margins so more cash can be reinvested in brands and capabilities.

02
Digital and commercial capability buildingmedium-term

Better consumer targeting and e-commerce execution are needed in a more fragmented retail environment.

03
Portfolio and strategic reviewshort-term

Portfolio optimization may improve growth quality and unlock value across brands and categories.

Kenvue faces pressure from powerful retailers, changing consumer preferences, and intense competition from CPG, pharma,...

high

Retail concentration and bargaining pressure

Large customers and buying alliances can demand more trade promotions, media support, and discounts, reducing profitability.

Scope
U.S. and global retail channels
Materiality
high
high

Consumer preference and demand volatility

The company depends on fast response to changing shopping patterns, seasonality, and regional trends.

Scope
Skin health, allergy, cough/cold, and OTC categories
Materiality
high
high

Supply chain and third-party manufacturing dependence

Kenvue relies on external partners and a global network, which reduces direct control over quality and continuity.

Scope
Global sourcing and manufacturing
Materiality
high
high

Cybersecurity and technology systems disruption

Digital strategy and third-party integrations increase exposure to breaches, outages, and data misuse.

Scope
Enterprise systems, e-commerce, and vendor networks
Materiality
medium
high

Regulatory, litigation, and product safety exposure

Consumer health products face FDA oversight, compliance scrutiny, and potential claims tied to safety or labeling.

Scope
OTC medicines and personal care products
Materiality
high
Revenue recognition and variable consideration
Can shift reported revenue and gross margin when estimates change
Seasonality and shipment timing
Affects comparability of quarterly sales and inventory levels
Goodwill and intangible asset impairment
Can create large non-cash charges and signal weaker category outlook
Restructuring and operating model optimization
Impacts operating expenses and near-term earnings
Tax and litigation contingencies
Can affect tax expense, reserves, and cash flows

PERRIGO Co plc

PRGO · Pharmaceutical Preparations

Prestige Consumer Healthcare Inc.

PBH · Pharmaceutical Preparations

ENvue Medical, Inc.

FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Kun Peng International Ltd.

KPEA · Services-Educational Services

Longduoduo Co Ltd

LDDD · Services-Health Services

Quoin Pharmaceuticals, Ltd.

QNRX · Pharmaceutical Preparations

: 11/08/2026